SALT LAKE CITY--(BUSINESS WIRE)--Great Basin Scientific, Inc. (Nasdaq:GBSN), a molecular diagnostics company, announced today it will provide preliminary revenue and customer acquisition results for the second quarter after market close on July 14, 2016. The Company also announced that it will host a business update call to discuss operational progress-to-date and provide further guidance on corporate objectives on the same day at 4:30 PM EDT.
Great Basin invites all interested parties to join this call by dialing (877) 407-0789. For those who are not able to listen live, the call will be archived for 90 days on the Investor Relations section of the Company’s website, www.gbscience.com.
About Great Basin Scientific
Great Basin Scientific is a molecular diagnostics company that commercializes breakthrough chip-based technologies. The Company is dedicated to the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases. The Company's vision is to make molecular diagnostic testing so simple and cost-effective that every patient will be tested for every serious infection, reducing misdiagnoses and significantly limiting the spread of infectious disease.
Forward-Looking Statements
This press release includes forward-looking statements regarding events, trends and business prospects, which may affect our future operating results and financial position, including statements regarding the Company’s revenues and customer acquisitions. Forward-looking statements involve risk and uncertainties, which could cause actual results to differ materially, and reported results should not be considered as an indication of future performance. These risk and uncertainties include, but are not limited to: (i) our limited operating history and history or losses; (ii) our ability to develop and commercialize new products and the timing of commercialization; (iii) our ability to obtain capital when needed; and (iv) other risks set forth in the Company's filings with the Securities and Exchange Commission, including the risks set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2015 and 10-Q for the quarter ended March 31 2016. These forward-looking statements speak only as of the date hereof and Great Basin Scientific specifically disclaims any obligation to update these forward-looking statements, except as required by law.
